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The possible role of the exposure to envi-
ronmental chemicals as a co-causal factor 
in the etiology of endometriosis has been 
the object of scientific debate in the last 20 
years. Endometriosis is a common gyneco-
logic disease characterized by the ectopic 
growth of endometrial tissue and is often 
associated with pelvic pain and/or infertil-
ity. It affects approximately 10% of women 
of reproductive age in Italy as well as in 
other industrialized countries (Eskenazi and 
Warner 1997; Gruppo Italiano per lo Studio 
dell’Endometriosi 1994), and its prevalence 
and severity are reported to be increasing in 
developing countries (Donnez et al. 2002).
Its etiology is unclear, although a multifac-
torial origin, resulting from the contribution 
of immunologic, genetic, and environmental 
factors, is considered to be most plausible. 
The hypothesis that exposure to immunotoxic 
endocrine-disrupting environmental pollut-
ants could play a role in the disease etiology 
first arose from the study of Rier and cowork-
ers (Rier et al. 1993). These authors observed 
a dose-dependent increase of incidence and 
severity of spontaneous endometriosis in a 
colony of monkeys chronically exposed to 
dioxin [2,3,7,8-tetrachloro  dibenzo-p-dioxin 
(2,3,7,8-TCDD)], the most toxic member 
of the family of polychlorinated dibenzo-p-
dioxins (PCDDs) and polychlorinated diben-
zofurans (PCDFs), 210 different molecules 
or congeners generally referred to as dioxins. 
Although criticized by some scientists (Guo 
2004; Hitchin 1994), this study opened the 
way to a number of studies on the relation-
ship between the disease and environmental 
pollutants. Major criticism involved the inci-
dental nature of the observation—endometri-
osis was not a prospectively defined end point 
of the experiment, and its presence in mon-
keys was observed many years after the end of 
the treatment—and appropriateness of statis-
tical analysis of the results. The small sample 
size (24 animals assigned to three groups of 
8 animals each), the limited values of dioxin 
exposure levels (a low-dose and a high-dose 
group), and the use of linear regression and 
t-test based on normality assumption were 
the study elements deemed to be more critical 
in interpreting study results. Together with 
dioxins, polychlorinated biphenyls (PCBs), 
a family of persistent and bioaccumulative 
industrial compounds widely used until the 
1980s, have been the pollutants principally 
investigated as to their possible role in the 
disease onset or progression. In the general 
population, diet accounts for over 90% of 
total exposure to dioxins and PCBs.
PCBs comprise 209 different congeners 
which, according to the structure, are grouped 
into 12 dioxin-like PCB (DL-PCB) conge-
ners, with no or only one chlorine in the ortho 
position, and non-dioxin-like PCBs (NDL-
PCBs), characterized by the presence of two 
or more chlorines in the ortho positions. The 
latter are normally much more abundant 
than DL-PCBs in environmental, food, and 
human specimens. The most abundant con-
geners in human tissues include NDL-PCBs 
28, 52, 101, 138, 153, and 180—referred 
to as ‘‘indicators’’ (Appel 2003) because 
conventionally they are used to estimate the 
overall PCB content in specimens of biologi-
cal origin (EFSA 2005)—along with a few 
others such as DL-PCB-105, DL-PCB-118, 
DL-PCB-156, and DL-PCB-167, and 
NDL-PCB-170, PCB-138, PCB-153, and 
PCB-180, are prevalent in all human tissues 
and account for 50–80% of total PCB con-
tent in serum (Glynn et al. 2000).
DL-PCBs have been the first PCB con-
geners to be considered in association with 
endometriosis because, as dioxins, they bind 
to the aryl hydrocarbon receptor (AhR) and 
elicit the same spectrum of toxic activities 
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Ba c k g r o u n d: Endometriosis is a common gynecologic disease characterized by the ectopic growth 
of endometrial tissue. In industrialized countries, it affects approximately 10% of women of repro-
ductive age. Its etiology is unclear, but a multifactorial origin is considered to be most plausible. 
Environmental organochlorinated persistent pollutants, in particular dioxins and polychlorinated 
biphenyls (PCBs), have been hypothesized to play a role in the disease etiopathogenesis. However, 
results of studies carried out on humans are conflicting.
oB j e c t i v e: We evaluated the exposure to organochlorinated persistent pollutants as a risk factor for 
endometriosis. 
Me t h o d s : We conducted a case–control study in Rome on 158 women comprising 80 cases and 
78 controls. In all women, serum concentrations of selected non-dioxin-like PCBs (NDL-PCBs) 
and dioxin-like PCBs (DL-PCBs), 1,1-dichloro-2,2,-bis(4-chlorophenyl)-ethene (p,p´-DDE), and 
hexachlorobenzene (HCB) were determined by ion-trap mass spectrometry. DR-CALUX bioassay 
was employed to assess the 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity equivalent (TEQ) concen-
trations of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), 
and DL-PCBs. 
re s u l t s: We found an increased risk of endometriosis for DL-PCB-118 [odds ratio (OR) = 3.79; 
95% confidence interval (CI), 1.61–8.91], NDL-PCB-138 (OR = 3.78; 95% CI, 1.60–8.94), NDL-
PCB-153 (OR = 4.88; 95% CI, 2.01–11.0), NDL-PCB-170 (OR = 3.52; 95% CI, 1.41–8.79), and 
the sum of DL-PCBs and NDL-PCBs (OR = 5.63; 95% CI, 2.25–14.10). No significant associa-
tions were observed with respect to HCB or to the sum of PCDDs, PCDFs, and DL-PCBs given as 
total TEQs.
co n c l u s i o n s: The results of this study show that an association exists between increased PCB and 
p,p´-DDE serum concentrations and the risk of endometriosis.
key w o r d s : biomonitoring, case–control study, dioxins, endometriosis, PCBs. Environ Health 
Perspect 117:1070–1075 (2009).  doi:10.1289/ehp.0800273 available via http://dx.doi.org/ [Online 
31 March 2009]Organochlorinated pollutants and endometriosis
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through the same mechanism of action. 
Indeed, DL-PCBs, rather than dioxins, were 
suggested to be associated with an endometri-
otic effect (Rier et al. 2001) when blood sam-
ples from exposed monkeys were analyzed 
years after the experiment was completed and 
significant concentrations of these compounds 
were detected, possibly originating from con-
taminated food.
On the epidemiologic side, several stud-
ies have been conducted to investigate the 
potential relationship between endometrio-
sis and dioxins and/or PCBs, including the 
non-dioxin-like congeners, but their results 
are conflicting. Major differences in study 
design, analytical methods, and the number 
and kinds of congeners measured make com-
parability (if any) between different studies 
limited, as recently discussed by some authors 
(Anger and Foster 2008; Heilier et al. 2008). 
In the last decade, the hypothesis of a correla-
tion between the disease and environmentally 
persistent organohalogenated compounds has 
been extended to include other organoha-
logenated pollutants present in human tis-
sues such as polybrominated biphenyls 
(PBBs) (Hoffman et al. 2007), hexachloro-
benzene (HCB), and 1,1-dichloro-2,2-bis(4-
chlorophenyl)-ethene (p,p´-DDE) (Lebel et al. 
1998; Tsukino et al. 2005), all characterized 
by endocrine-disrupting and immunotoxic 
activity (Agency for Toxic Substances and 
Disease Registry 2002; Blanck et al. 2000; 
Davis et al. 2005; Foster et al. 1992, 1995; 
Halloway et al. 2005; Reed et al. 2007; 
Windham et al. 2005). No significant associa-
tion for these pollutants has been evidenced 
in the studies performed to date.
In previous studies carried out to inves-
tigate a possible association between organo-
chlorinated compounds and endometriosis, 
we found significantly higher concentrations 
of some of the most abundant PCBs and 
higher concentrations of p,p´-DDE, in women 
affected by the disease (Porpora et al. 2006; 
Quaranta et al. 2006). We also observed that 
such increased concentrations were associ-
ated with altered natural killer (NK) immune 
responses (Quaranta et al. 2006). On the con-
trary, no increase in blood concentrations of 
dioxin-like chemicals (PCDDs, PCDFs, and 
the sum of the 12 DL-PCBs) was observed 
in women affected by the disease at different 
degrees (De Felip et al. 2004).
The present study was funded by Italy’s 
Ministry of Health and National Institute 
for Health in the context of research activities 
aimed to characterize the risk for women’s 
reproductive health from exposure to persis-
tent organic pollutants of environmental ori-
gin. It is the largest study carried out in Italy 
on the possible association between endo-
metriosis and persistent organochlorinated 
pollutants of high toxicologic relevance. 
Methods
Patients. Of the 312 women who under-
went laparoscopy between January 2002 
and December 2005 at the Department of 
Gynaecology and Obstetrics, Policlinico 
Umberto I, University of Rome Sapienza, for 
endometriosis or other benign gynecologic 
conditions, 158 patients were enrolled in the 
study. The vast majority of women participat-
ing in the study underwent surgery between 
March 2004 and October 2005. The protocol 
of this study was approved by the Sapienza 
University, School of Medicine, Institutional 
Review Board. All patients met the inclu-
sion criteria: 18–45 years of age, residence in 
Rome in the last 5 years, no breast-feeding 
history, absence of immunologic, hormonal 
disorders, or chronic diseases, and no occupa-
tional exposure to PCBs or pesticides. 
All enrolled women signed an informed 
consent form. A physician unaware of the 
indications to laparoscopy administered a 
questionnaire before surgery which docu-
mented age, education, job, medical, gyneco-
logic and obstetric history, height and weight, 
and smoking and dietary habits. The ques-
tionnaire was designed to obtain information 
on potential confounders, including metabolic 
diseases, gravidity, parity, and weight changes 
in the last years. A detailed medical and gyne-
cologic history was taken, and all patients 
underwent clinical and ultrasound examina-
tions. For each woman, the body mass index 
(BMI) was calculated. Before laparoscopy, a 
blood specimen of approximately 30 mL was 
collected from the cubital vein in Vacutainer 
tubes and centrifuged. Serum specimens were 
stored at –20°C until subjected to analysis. 
A 10-mm laparoscopy was performed under 
general anesthesia. The presence of endo-
metriosis was confirmed by histologic analy-
sis of lesions, and the disease was staged in 
80 women according to the revised American 
Society of Reproductive Medicine (ASRM) 
classification. The control group consisted of 
women without complaints of infertility or 
pelvic pain who were undergoing laparoscopy 
for benign gynecologic conditions and had 
no visual evidence and histologic features of 
endometriosis in random peritoneal biopsies.
The questionnaire administered to docu-
ment dietary habits included 16 questions on 
the frequency of consumption (times/month) 
of various milk, meat, and fish products.
Analysis of serum samples: polychloro-
biphenyls and pesticides. Serum samples were 
added with a mixture of 13C-labeled internal 
standards (Cambridge Isotope Laboratories 
Inc., Andover, MA, USA) comprising PCB-
28, PCB-52, PCB-101, PCB-118, PCB-138, 
PCB-153, PCB-156, and PCB-180, HCB, 
and p,p´-DDE and kept overnight at 4°C. 
Before extraction, we thawed the spiked sam-
ples at room temperature, added a 4:1 (vol/vol) 
mixture of formic acid and iso-propanol (J.T. 
Baker, Phillipsburg, NJ, USA), and sonicated 
them. Extraction was performed with five 
6-mL aliquots of n-hexane (Merck KGaA, 
Darmstadt, Germany) by manual shaking, fol-
lowed by centrifugation at 3,500 revolutions 
per minute (rpm) for 5 min. We removed the 
n-hexane aliquots collected from centrifuga-
tion, pooled them in a centrifuge tube, and 
carefully concentrated them. Concentrated 
sulfuric acid (H2SO4, Carlo Erba, Milan, 
Italy) was added to the n-hexane extracts; the 
two phases were vigorously shaken and then 
separated by centrifugation (3,500 rpm for 20 
min). We reduced the volume of the purified 
extracts and transferred them into 1-mL vials 
to undergo instrumental analysis. 
Instrumental analysis was carried out by 
using ion trap mass spectrometry (IT-MS) 
(Polaris Q; Thermofisher Scientific Inc., 
Waltham, MA, USA) coupled with high-
resolution gas chromatography (GC). A 
RTX-5MS 60-m length, 0.25-mm i.d. cap-
illary column (Restek Corporation, State 
College, PA, USA) coated with a 0.25-µm 
film was employed to separate the extracted 
compounds. The initial oven temperature 
of 70°C was increased to 190°C at a rate of 
30°C/min, subsequently to 280°C at 5°C/min 
and to 330°C at 20°C/min, and maintained 
at 330°C for 4 min (total GC run time was 
28 min). The injector was operated in the 
splitless mode with a 1.5-min splitless time. 
The initial injector temperature of 70°C was 
increased to 280°C at a rate of 14.5°C/sec. 
The transfer line and the ion source tem-
peratures were set at 290 and 250°C, respec-
tively. The IT-MS detector was operated in 
the electron ionization mode (70 eV) and 
MS/MS mode. Selected daughter ions used 
for quantification were (analyte, daughter 
ion): PCB-28, PCB-186; PCB-52, PCB-257; 
PCB-101, PCB-291; PCB-105, PCB-256; 
PCB-118, PCB-256; PCB-138 and PCB-153, 
PCB-325; PCB-156 and PCB-167, PCB-290; 
PCB-170 and PCB-180, PCB-361; HCB-
249; p,p´-DDE-248. Data were processed 
using the XCALIBUR software (Thermofisher 
Scientific Inc.). Based on the 13C-labeled 
compounds employed, recovery ranges were 
within 75–110% for all compounds. Analytic 
reliability was warranted by the use of an in-
house validated method (Ingelido et al. 2008). 
The laboratory has a consolidated experience 
in the analysis of halogenated organic micro-
contaminants and periodically participates 
in interlaboratory exercises concerning the 
analysis of PCDDs, PCDFs, PCBs, organo-
chlorinated pesticides, and some brominated 
flame retardants in dietary, biological, and 
environ  mental matrices. 
Analysis of serum samples: compounds 
with dioxin-like activity. We conducted the 
analysis of compounds eliciting dioxin-like Porpora et al.
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activity by the dioxin receptor (DR or AhR)-
driven chemically activated luciferase expres-
sion bioassay (DR-CALUX; BioDetection 
Systems, Amsterdam, The Netherlands), a 
bioanalytic tool used to detect AhR active 
compounds, such as dioxins, present in dif-
ferent environmental and biological matrices 
(Hoogenboom et al. 1999; Murk et al. 1997). 
DR-CALUX cells were purchased from 
BioDetection Systems. We cultured them 
routinely in a 5% CO2 atmosphere at 37°C in 
Alpha MEM supplemented with 10% heat-
inactivated fetal calf serum (GIBCO BRL, 
Gaithersburg, MD, USA). The luciferase 
assay system, Britelite kit, was purchased 
from PerkinElmer Life and Analytical Science 
(Boston, MA, USA). 
Analysis involved liquid-liquid extraction 
of blood serum with a 97:3 (vol/vol) mix-
ture of n-hexane and diethyl ether and lipid 
removal by eluting the extract on a silica gel 
column concentrated H2SO4. The purified 
extract was quantitatively transferred to a vial, 
evaporated, and dissolved in dimethyl sulfox-
ide (DMSO) for DR-CALUX measurement. 
DR-CALUX cells were seeded in 96-multi-
well plates (Packard ViewPlate, PerkinElmer) 
and incubated for 24 hr in a CO2 incubator. 
We performed the cell treatments in tripli-
cate, adding to each well 100 µL of sample 
extract diluted in culture medium just before 
use, using DMSO as vehicle (0.5%, vol/vol 
DMSO in culture medium). After 24 hr of 
incubation at 37°C, cell monolayers were 
checked under an inverted microscope to 
exclude any cytotoxic effects of the extracts. 
We removed the exposure medium, washed 
the cells with phosphate-buffered saline 
with calcium and magnesium (pH 7.4), and 
lysed them with 100 µL Britelite solution. 
Light production was immediately measured 
with a MicroBeta luminescence counter 
(MicroBeta Jet, 1450 LSC, PerkinElmer). We 
always included a standard calibration curve 
of 2,3,7,8-TCDD in the experiments and 
simultaneously analyzed it with the samples 
(Sanderson et al. 1996; Windal et al. 2005). 
Eight 2,3,7,8-TCDD concentrations (0.3–300 
pM/well), dissolved in DMSO and processed 
as described for sample extracts, were tested. 
Results expressed as relative light unit values 
were transformed into 2,3,7,8-TCDD toxicity 
equivalents (TEQs) using the BioDetection 
Excel file. Results were expressed in picograms 
of DR-CALUX-TEQs (C-TEQs) per gram 
of serum fat (pgC-TEQs/g fat). The limit of 
detection was calculated as the signal measured 
from the DMSO solvent control on each well 
plate plus three times its standard deviation.
Lipid analysis. Concentrations of total 
cholesterol, phospholipids, and triglycer-
ides were determined by enzymatic methods 
(Ingelido et al. 2008) and the use of colori-
metric kits (Futura System s.r.l., Rome, Italy). 
Sample size. In setting the study design, 
sample size estimation was performed to 
determine the number of women per group 
sufficient to detect a true odds ratio (OR) 
between 2.5 and 3.0. With a power of 80%, 
type 1 error of 5%, and 0.20 probability of 
exposure in controls, we calculated that 64–94 
subjects (ORs = 3.0 and 2.5, respectively) were 
required per group. A retrospective power 
analysis based on 80 cases and 78 controls 
enrolled in the study and a significance level 
of α set to 5% provided a power estimation 
of 72.6% to detect a risk of 2.5 and 88% to 
detect a risk of 3.0. 
Statistical analysis. Serum concentrations 
of all the analytes determined were subjected 
to statistical analysis. Differences in analyte 
levels between groups were investigated; geo-
metric rather than arithmetic means were 
employed. The statistical significance of differ-
ences between cases and controls was assessed 
by Student’s t-test. 
The concentration distribution of each ana-
lyte was divided by tertiles, and women were 
classified at low, medium, and high exposure. 
Using unconditional logistic regression anal-
ysis to adjust for potential confounders, the 
adjusted ORs and 95% confidence intervals 
(CIs) were estimated for the second and third 
tertile of PCBs, C-TEQs, HCB, and p,p´-DDE. 
Variables included in the final model were age 
(years), BMI (kilograms per square meter), 
smoking habits (nonsmokers, exsmokers, smok-
ers), and evidence of relevant weight modifica-
tions in the last 5 years (> 10 kg). In addition, 
with the aim to investigate whether different 
histopathologic features of endometriosis were 
related to different etiologic risk factor pat-
terns, patients were classified according to the 
presence of ovarian endometrioma, peritoneal 
lesion, and deep lesions, and the groups were 
compared. The relationship between the sever-
ity of disease, according to the revised American 
Society of Reproductive Medicine (ASRM) 
classification and the detected chemical levels 
Table 1. Laparoscopic findings and stage of endo-
metriosis classified according to rASRM (1997) in 
women affected by endometriosis (cases).
Laparoscopic findings  Cases [no. (%)]
Stage of endometriosis (rASRM)
  I  8 (10.0)
  II  5 (6.2)
  III  44 (55.0)
  IV  23 (28.7)
Ovarian endometrioma
  Yes  72 (90.0)
  No  8 (10.0)
Peritoneal lesions
  Yes  45 (56.2)
  No  35 (43.7)
Type of peritoneal lesion
  Typical  23 (53.5)
  Subtle  6 (13.9)
  Both  14 (32.6)
Deep endometriosis
  Yes  6 (7.5)
  No  74 (92.5)
Table 2. Sociodemographic characteristics of cases (n = 80) and controls (n = 78).
Characteristics  Controls   Cases   p-Valuea
Age [years (mean ± SD)]  29.5 ± 6.1  31.6 ± 6.0  0.03
Age (years)
  ≤ 25   18 (23.1)  12 (15.0) 
  26–35  46 (59.0)  46 (57.5) 
  ≥ 36  14 (17.9)  22 (27.5)  0.23
No. of childrenb
  0  74 (94.9)  74 (96.1) 
  1  4 (5.1)  2 (2.6) 
  2  0 (—)  1 (1.3)  0.99
BMI (mean ± SD)  22.4 ± 4.6  21.1 ± 2.8  0.03
Relevant weight modifications in the  
  last 5 years (> 10 kg)b
  Yes  9 (11.5)  8 (10.1) 
  No  69 (88.5)  71 (89.9)  0.98
Food consumption [times/month (mean ± SD)]
  Milk and dairy products  33 ± 16  41 ± 25  0.02
  Meat  25 ± 10  25 ± 12  0.93
  Fish  7 ± 5  8 ± 6  0.49
Age at menarche [years (mean ± SD)]  12.1 ± 1.4  12.2 ± 1.5  0.84
Breast-fed as childrenb
  Yes  55 (70.5)  56 (70.9) 
  No  13 (16.7)  15 (19.0) 
  Unknown  10 (12.8)  8 (10.1)  0.83
Smoking status
  Nonsmokers  41 (53.9)  44 (55.0) 
  Ex-smokers  7 (9.2)  13 (16.2) 
  Smokers (cigarettes/day)
  1–9  8 (10.5)  7 (8.8) 
  10 –19  13 (17.1)  8 (10.0) 
  ≥ 20  7 (9.3)  8 (10.0)  0.54
Values shown are mean ± SD or no. (%)
aStudent’s t- test, chi-square test, Fisher test. bNumbers do not add up due to missing values.Organochlorinated pollutants and endometriosis
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was assessed by analysis of variance and chi-
square test. Multiple linear regression analysis 
was used to test the association between log-
transformed PCB concentrations in serum and 
dietary habits (milk, meat, fish) after checking 
for potential confounders.
Results 
A total of 158 women were enrolled in the 
study, 80 cases and 78 controls. Among 
cases, there were eight patients with stage I 
endometriosis, 5 with stage II, 44 with stage 
III, and 23 with stage IV. In particular, deep 
endometriotic nodules were present in 6 
women (7.5%), ovarian endometriomas were 
observed in 72 patients (90.0%), and perito-
neal implants in 45 cases (56.2%) (Table 1). 
The control group consisted of 78 women with 
other benign gynecologic conditions, including 
eight uterine myomas and 70 adnexal masses, 
with no laparoscopic evidence of endometriosis 
and random peritoneal biopsies negative for 
the disease at histologic analysis. 
The main characteristics of the studied pop-
ulation, as derived from the administered ques-
tionnaires, are shown in Table 2. Mean age at 
interview was slightly higher in cases (31.6 ± 6.0 
years) compared with controls (29.5 ± 6.1 years). 
Moreover, cases had a lower BMI (21.1 ± 2.8) 
than controls (22.4 ± 4.6). Both these differences 
were taken into account using a multivariate 
analysis. Age at menarche, having been breast-
fed, smoking habits, and alcohol consumption 
did not significantly differ between the groups. 
Dietary habits, described by the analysis of the 
dietary intakes of the main categories of food-
stuffs, were not significantly different in the case 
of meat and fish. Average monthly consumption 
of milk and dairy products was slightly differ-
ent among cases and controls (41 vs. 33 times/
month), but the associated incremental risk of 
endometriosis could be considered negligible 
(OR = 1.02; 95% CI, 1.00–1.04). 
Geometric means and pertinent CIs of 
the analytes assessed in cases and controls are 
shown in Table 3. The concentrations of all 
the analyzed PCBs were higher in cases than 
in controls. Significant differences (p < 0.05) 
were found for PCB-101, PCB-156, and 
PCB-170, and highly significant differences 
(p < 0.01) were found for PCB-52, PCB-118, 
PCB-138, PCB-153, and PCB-180. p,p´-DDE 
and total PCB serum concentrations, as the 
sum of all the 11 congeners analyzed, were also 
significantly higher (relative increase: 44.9 and 
48.4%, respectively) in cases than in controls. 
As for the AhR ligands that elicit a 
response of the DR-CALUX system [dioxins, 
DL-PCBs, and possibly other (pseudo) planar 
aromatic pollutants present in serum], no sig-
nificant difference was detected between cases 
and controls, despite the observed increase of 
two DL-PCBs (PCB-118, p = 0.0002, and 
PCB-156, p = 0.01) in women with endo-
metriosis. However, as noted above, C-TEQs 
account for all compounds with dioxin-like 
activity, with PCBs 118 and 156 likely provid-
ing a minor contribution. 
Table 4 shows the frequency distributions 
of all the analytes divided by tertiles, as well as 
the results of the multivariate analysis adjusted 
for age at interview, smoking habits, BMI, and 
weight loss. Concentrations of PCB congeners 
118, 138, 153, and 170 are associated with a 
significant increased risk of endometriosis for 
the second and third tertile when compared 
with the lowest tertile. Risk of endometriosis 
appears to be significant (OR = 3.05; 95% CI, 
1.25–7.42) also for the highest serum concen-
trations of PCB-180 (≥ 60.5 ng/g fat).
As to the sum of all PCB congeners, 
patients in the mid and upper tertiles have a 4- 
to 5-fold increased risk of having the disease.
Covariate-adjusted ORs showed that no 
increased risk of endometriosis was associated 
with serum levels of HCB, p,p´-DDE, and 
total C-TEQs, the latter determined by the 
DR-CALUX bioassay.
To explore a possible correlation between 
analyte serum concentrations and the disease 
type and localization, we stratified cases by 
peritoneal, deep, or ovarian endometriosis 
and compared levels of total PCBs, C-TEQs, 
HCB, and p,p´-DDE among groups. No dif-
ferences in mean analyte levels could be found 
Table 3. Serum concentrations [geometric mean (95% CI); ng/g fat] of PCBs, C-TEQs, HCB, and p,p´-DDE in 
cases and controls.      
  Controls  Cases   p-Valuea
PCB-28  3.4 (2.5–4.5)  4.3 (3.1–6.0)  0.3
PCB-52  1.6 (1.3–1.9)  2.2 (1.9–2.6)   < 0.01
PCB-101  1.6 (1.3–1.9)  2.1 (1.7–2.5)  0.04
PCB-105  5.7 (4.1–8.1)  6.8 (4.9–9.4)  0.47
PCB-118  15.2 (13.1–17.6)  23.4 (19.7–27.9)   < 0.01
PCB-138  33.8 (29.0–39.3)  50.7 (43.4–59.1)  < 0.01
PCB-153  61.8 (51.8–73.8)  99.8 (87.5–113.8)  < 0.01
PCB-156  5.7 (4.7–6.9)  8.3 (6.7–10.4)  0.01
PCB-167  2.5 (2.0–3.1)  3.2 (2.6–3.9)  0.08
PCB-170  6.1 (4.8–7.7)  8.8 (7.1–10.8)  0.02
PCB-180  34.4 (29.0–40.8)  48.6 (42.0–56.2)  < 0.01
Total PCBs  203.0 (179.4–229.8)  301.3 (271.1–334.9)   < 0.01
(pgC-TEQs/g fat)  20.9 (17.3–25.2)  18.6 (14.5–23.9)  0.47
HCB  40.9 (32.6–51.4)  35.8 (28.6–44.8)  0.41
p,p´-DDE  303.1 (247.0–371.9)   439.1 (360.4–534.9)  0.01
at-Test on log-transformed values.
Table 4. Frequency distribution of serum levels of 
PCB, C-TEQs, HCB, and p,p´-DDE and adjusted ORs 
for endometriosis by tertiles. 
Concentration  Controls  Cases   
(ng/g fat)  (%)  (%)  ORadj
a (95% CI)
PCB-28 
  ≤ 2.3  29.49  37.50  1.0 
  2.4–6.5  43.59  25.00  0.35 (0.15–0.84)
  ≥ 6.9  26.92  37.50  0.98 (0.42–2.25)
PCB-52
  ≤ 1.4   41.03  27.50  1.0 
  1.5–2.4  35.90  35.00  1.51 (0.68–3.35)
  ≥ 2.5  23.08  37.50  1.96 (0.84–4.56)
PCB-101       
  ≤ 1.35   39.74  30.00  1.0 
  1.36–2.4  34.62  30.00  1.29 (0.57–2.90)
  ≥ 2.5  25.64  40.00  1.93 (0.86–4.36)
PCB-105      
  ≤ 3.7   35.90  31.25  1.0 
  3.8–11.2   34.62  32.50  1.23 (0.55–2.75)
  ≥ 11.3  29.49  36.25  1.55 (0.68–3.50)
PCB-118      
  ≤ 13.2   48.72  21.25  1.0 
  13.3–24.2   25.64  38.75  3.17 (1.36–7.37)
  ≥ 24.3  25.64  40.00  3.79 (1.61–8.91)
PCB-138      
  ≤ 33.6   46.15  21.25  1.0 
  33.7–56  29.49  36.25  2.37 (1.02–5.48)
  ≥ 57  24.36  42.50  3.78 (1.60–8.94)
PCB-153      
  ≤ 62  51.28  16.25  1.0 
  63–104   24.36  42.50  4.64 (1.93–11.1)
  ≥ 105  24.36  41.25  4.88 (2.01–11.0)
PCB-156      
  ≤ 4   39.74  27.50  1.0 
  5–9   34.62  33.75  0.98 (0.43–2.24)
  ≥ 10  25.64  38.75  1.65 (0.71–3.82)
PCB-167      
  ≤ 1.9  35.90  31.25  1.0 
  2–3.9   34.62  32.50  0.97 (0.43–2.17)
  ≥ 4  29.49  36.25  1.18 (0.50–2.77)
PCB-170      
  ≤ 5.37   45.95  21.25  1.0 
  5.38–12.4  29.73  37.50  2.71 (1.13–6.51)
  ≥ 12.5  24.32  41.25  3.52 (1.41–8.79)
PCB-180      
  ≤ 33.2   43.24  23.75  1.0 
  33.3–60.4  35.14  32.50  1.33 (0.57–3.11)
  ≥ 60.5  21.62  43.75  3.05 (1.25–7.42)
Total PCBs      
  ≤ 208  51.35  16.25  1.0 
  209–305   25.68  41.25  4.64 (1.93–11.16)
  ≥ 306  22.90  42.50  5.63 (2.25–14.10)
(pgC-TEQs/g fat)       
  ≤ 15.6  30.2  35.7  1.0 
  15.7–29.5  35.8  30.4  0.52 (0.18–1.48)
  ≥ 29.6  34.0  33.9  0.73 (0.26–2.01)
HCB      
  ≤ 31  35.90  33.75  1.0 
  32–54   30.77  35.00  0.91 (0.40–2.08)
  ≥ 55  33.33  31.25  0.65 (0.27–1.54)
p,p´-DDE       
  ≤ 231   41.03  26.25  1.0 
  232–492  30.77  35.00  1.54 (0.66–3.58)
  ≥ 493  28.21  38.75  2.14 (0.93–4.93)
aOR adjusted for age, smoking habits, BMI, evidence of 
weight modification.Porpora et al.
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in women with endometriosis with respect to 
the different kind of disease. 
Furthermore, the association between 
serum concentrations of the analyzed organo-
chlorinated compounds and the stage of the 
disease (according to the revised ASRM classi-
fication) was investigated. No significant dif-
ferences between groups were observed: Data 
analysis showed that pollutant concentrations 
did not correlate with disease severity. 
The relationship between different food 
intakes and values of PCBs, C-TEQs, HCB, 
and p,p´-DDE was estimated by a multivari-
ate regression model. The lack of significance 
(p > 0.05) of slope coefficients suggests that 
food intake is not associated with the con-
centrations of the chemicals analyzed in the 
present study. 
Discussion
The results of the present study are in agree-
ment with findings we had obtained in two 
previous investigations carried out on smaller 
samples of nulliparous women, in which cases 
resulted to have a significant increase in blood 
concentrations of PCB-118, PCB-138, PCB-
153, PCB-180, the sum of the mentioned 11 
PCBs (Porpora et al. 2006; Quaranta et al. 
2006), as well as of p,p´-DDE (Quaranta et al. 
2006). In particular, a greater than 3-fold 
increase was found for these four PCB conge-
ners and their sum.
The observed absence of an increase in 
TEQ values in women with endometriosis 
with respect to controls confirms the results 
we obtained in a study carried out on pooled 
blood samples from two small groups of 
Italian and Belgian women of reproductive 
age (De Felip et al. 2004), in which no corre-
lation was observed between dioxin-like com-
pounds and the disease, on a country basis. 
This agreement is observed although different 
analytical methodologies were used: High-
resolution GC coupled with high resolution 
mass spectrometry was employed to deter-
mine dioxin-like compounds in our previ-
ous study, whereas DR-CALUX bioassay was 
used in this work.
The present study and the three above 
have similar study designs. In fact, with the 
exception (in this study) of a small minority 
of non-nulliparous women who had never 
breastfed, only nulliparous women were 
enrolled, to avoid the confounding factor of 
breast-feeding, known to determine a signifi-
cant decrease in organochlorine body burden. 
All women underwent surgical confirmation 
of the disease or its absence, and only women 
with no visual evidence or histologic signs 
of endometriosis in random peritoneal biop-
sies were included in the control group. In 
the present study, women with complaints 
of infertility were not enrolled as controls, 
because some organochlorinated pollutants 
have been hypothesized to be associated with 
infertility, in particular p,p´-DDE (Korrick 
et al 2001; Weiss et al. 2006). There are no 
data regarding a correlation between the other 
gynecologic conditions of the control group 
(uterine myomas, benign adnexal mass) and 
the aforesaid pollutants.
A comparison of this study with other 
case–control studies designed to explore 
the association between persistent organo-
halogenated pollutants and endometriosis is 
complicated by the variety of study designs, 
analytical methodologies used, and number 
and type of compounds or congeners assessed. 
Recent papers (Anger and Foster 2008; 
Heilier et al. 2008) have presented a compre-
hensive overview of the studies carried out on 
this topic, the vast majority focused on assess-
ing the association between dioxins and/or 
PCBs and peritoneal endometriosis, and have 
discussed their limited or null comparabil-
ity. On the whole, no significant correlation 
was observed in case–control studies between 
NDL-PCBs and/or DL-PCBs and endo-
metriosis (Buck Louis et al. 2005; Fierens 
et al. 2003; Gerhard and Runnebaum 1992; 
Heilier et al. 2004, 2005; Lebel et al. 1998; 
Pauwels et al. 2001; Tsukino et al. 2005), 
although a nonsignificant increase of the most 
abundant NDL-PCB-138, PCB-153, and 
PCB-180 was observed in one study (Gerhard 
and Runnebaum 1992) and of the same three 
congeners plus the DL-PCB-118 in another 
study (Pauwels et al. 2001). 
As to the sparse case–control studies avail-
able specifically focused on the AhR ligands 
(PCDDs, PCDFs, and DL-PCBs), a significant 
association with these chemicals and the disease 
was generally not observed (Anger and Foster 
2008; Pauwels et al. 2001), whereas a few stud-
ies reported increased but not significant ORs 
for the disease (Buck Louis et al. 2005; Heilier 
et al. 2005; Mayani et al. 1997). In one study 
that considered peritoneal endometriosis and 
deep endometriotic (adenomyotic) nodules 
separately (Heilier et al. 2005), a significantly 
increased risk was associated with dioxin and 
DL-PCB serum concentrations in women with 
deep endometriosis. 
As to the association between endometrio-
sis and organohalogenated pollutants other 
than PCBs and/or dioxins, only a few studies 
are available, carried out on PBBs (Hoffman 
et al. 2007) or organochlorinated pesticides, 
including HCB and p,p´-DDE (Tsukino 
et al. 2005). No evidence of an association 
was found between endometriosis and PBB 
or organochlorinated pesticide serum levels in 
these studies. 
In our study, no correlation was observed 
between the disease and HCB, a ubiquitous 
persistent pollutant identified in human tis-
sues worldwide, although its use was discon-
tinued decades ago. The effects of HCB on 
ovarian function and circulating ovarian ste-
roids were demonstrated on exposed nonhu-
man primates (Foster et al. 1995). 
With regard to p,p´-DDE, the main 
metabolite of the pesticide p,p´-DDT char-
acterized by both immune and endocrine 
toxicity (Halloway 2005; Wójtowicz et al. 
2007), findings from the present investigation 
confirm an increase in serum concentrations 
in women with endometriosis observed in 
a previous investigation. In that study, on 
the basis of the reported observation of an 
immunologic dysregulation in women simul-
taneously exposed to p,p´-DDE and PCBs 
(Daniel et al. 2002), we evaluated the immu-
nologic status of two small groups of women 
and determined the serum concentrations of 
the most abundant PCBs and p,p´-DDE to 
evaluate their possible role in dysregulation 
of the immune function observed in patients 
with endometriosis. The results we obtained 
showed that peripheral blood NK cytotoxic 
activity and interleukin-1 beta and interleu-
kin-12 production were significantly down-
regulated in patients with endometriosis with 
respect to controls, and this matched with 
higher serum concentrations of PCBs and 
p,p´-DDE in the same patients (Quaranta 
et al. 2006). 
In addition to peritoneal endometriosis, 
deep endometriosis (adenomyotic) nodules 
of the recto-vaginal septum, considered a dis-
tinct clinical entity by some authors (Donnez 
et al. 1996), have also been studied as to their 
potential association with exposure to organo-
chlorinated pollutants. For this type of endo-
metriosis, Heilier and coworkers (Heilier et al. 
2004, 2005) found a significantly increased risk 
associated with both NDL-PCBs and dioxin-
like compounds in serum. When we analyzed 
the association between the serum concentra-
tions of PCBs and pesticides and the differ-
ent types of disease, no differences were found 
between cases with peritoneal implants, ovar-
ian endometrioma, deep lesions, or combined 
lesions. Therefore, it can be hypothesized that 
PCBs and p,p´-DDE are risk factors for devel-
oping any kind of endometriosis. Regarding 
the relationship between the severity of disease 
(according to the ASRM classification) and 
exposure to organochlorinated compounds, we 
did not find any significant correlation between 
the pollutant serum concentrations and the dif-
ferent stages of the disease.
The reason for the observed increase in 
PCB and p,p´-DDE serum concentrations in 
patients with endometriosis remains to be elu-
cidated. Because no correlation with dietary 
habits was found, such an increase could be 
associated with a different capacity in bio-
activation and/or detoxication due to both 
genetic makeup and/or induction/inhibition 
phenomena in the tested population. Work 
is in progress on genetic polymorphisms of Organochlorinated pollutants and endometriosis
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glutathione S-transferase and cytochrome 
P-450, enzymes involved in organochlorine 
compound biotransformation, to explore 
the gene–environment interactions as a pos-
sible cause of the observed higher levels of the 
aforesaid compounds in patients with endo-
metriosis and as a risk factor for the disease 
onset/progression, as suggested by some stud-
ies (Ertunc et al. 2005; Hsieh et al. 2004; 
Tsuchiya et al. 2007).
In summary, our data show that expo-
sure to PCBs and p,p´-DDE represents a risk 
factor for endometriosis. In particular, the 
observation that ORs increase with increas-
ing PCB concentrations strongly supports the 
hypothesis of an association between exposure 
to these chemicals and the disease, although 
the specific mechanisms of actions remain to 
be characterized.
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